Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer

Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA
Phase III trial shows crizotinib superior to single-agent chemotherapy for ALK-positive lung cancer ( Dr Alice Shaw - Massachusetts General Hospital Cancer Center, Boston, USA )
30 Sep 2012

Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma

Dr Wyndham Wilson - National Cancer Institute, Bethesda, MD, USA; Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman - Roswell Park Cancer Institute, Buffalo, NY, USA; Prof John Gribben - Bart’s and
Key topics from day 2 of the 10th International Workshop on Non-Hodgkin's Lymphoma ( Dr Wyndham Wilson -  National Cancer Institute, Bethesda, MD, USA;  Prof. Owen O’Conner – New York University Cancer Institute and Lagone Medical Centre; Dr Myron Czuczman -  Roswell Park Cancer Institute, Buffalo, NY, USA;  Prof John Gribben - Bart’s and )
26 Sep 2012

Highlights from the 17th International Conference on Cancer Nursing

Greta Cummings – President of the International Society of Nurses of Cancer Care
Highlights from the 17th International Conference on Cancer Nursing ( Greta Cummings – President of the International Society of Nurses of Cancer Care )
21 Sep 2012

ASCO / ONS Chemotherapy Standards

Kris LeFebvre – Oncology Nursing Society, Pittsburgh, USA
ASCO / ONS Chemotherapy Standards ( Kris LeFebvre – Oncology Nursing Society, Pittsburgh, USA )
21 Sep 2012

Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication

Elaine Lennan – University Hospital Southampton NHS Foundation Trust, UK
Best practice in nurse-led chemotherapy, standardising services, as well as electronic prescriptions and nurse-physician communication ( Elaine Lennan – University Hospital Southampton NHS Foundation Trust, UK )
20 Sep 2012

Training for outpatient treatment procedures

Anne Gross – Dana Farber Cancer Institute, Boston, USA
Training for outpatient treatment procedures ( Anne Gross – Dana Farber Cancer Institute, Boston, USA )
20 Sep 2012

Molecular stratification of breast cancer: reaching the clinic

Prof Carlos Caldas - University of Cambridge, UK
Molecular stratification of breast cancer: reaching the clinic ( Prof Carlos Caldas - University of Cambridge, UK )
25 Jul 2012

An improving outlook for liver cancer patients

Dr Graeme Poston - University Hospital Aintree, Liverpool, UK
An improving outlook for liver cancer patients ( Dr Graeme Poston - University Hospital Aintree, Liverpool, UK )
23 Jul 2012

Epithelial mesenchyme transition in cancer cells

Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore
Epithelial mesenchyme transition in cancer cells ( Prof Jean-Paul Thiery – Institute of Molecular and Cell Biology, Singapore )
18 Jul 2012

Strategies to improve the tolerability of treatment in patients with multiple myeloma

Prof Michel Delforge - Catholic University, Leuven, Belgium
Strategies to improve the tolerability of treatment in patients with multiple myeloma ( Prof Michel Delforge - Catholic University, Leuven, Belgium )
13 Jul 2012

Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012

Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands,
Emerging advances in multiple myeloma; expert roundtable at MM CTP 2012 ( Prof Thierry Facon - Centre Hospitalier Universitaire, France, Prof Pieter Sonneveld - University Hospital Rotterdam, Netherlands, )
13 Jul 2012

Best treatment for chronic lymphocytic leukaemia with 17p deletion

Prof Michael Keating - MD Anderson Cancer Center, Houston, USA
Best treatment for chronic lymphocytic leukaemia with 17p deletion ( Prof Michael Keating - MD Anderson Cancer Center, Houston, USA )
12 Jul 2012